Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obesity
  Free Subscription

Articles published in
Lancet
    April 2024
  1. THE LANCET EDITORS
    Retraction and republication-Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.
    Lancet. 2024;403:1321.
    >> Share

  2. SHI Q, Wang Y, Hao Q, Vandvik PO, et al
    Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.
    Lancet. 2024;403:e21-e31.
    >> Share

  3. BUTLER J, Shah SJ, Petrie MC, Borlaug BA, et al
    Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
    Lancet. 2024 Apr 4:S0140-6736(24)00469-0. doi: 10.1016/S0140-6736(24)00469.
    >> Share

  4. DONAL E, L'Official G, Istratoaie S
    Semaglutide-a new treatment for obesity-related heart failure with preserved ejection fraction?
    Lancet. 2024 Apr 4:S0140-6736(24)00653-6. doi: 10.1016/S0140-6736(24)00653.
    >> Share

    March 2024
  5. JOHANSSON K, Bodnar LM, Stephansson O, Abrams B, et al
    Safety of low weight gain or weight loss in pregnancies with class 1, 2, and 3 obesity: a population-based cohort study.
    Lancet. 2024 Mar 28:S0140-6736(24)00255-1. doi: 10.1016/S0140-6736(24)00255.
    >> Share

  6. GAILLARD R
    Optimising gestational weight gain among pregnant women with obesity.
    Lancet. 2024 Mar 28:S0140-6736(24)00470-7. doi: 10.1016/S0140-6736(24)00470.
    >> Share

    February 2024
  7. TUMAS N, Lopez SR
    Double burden of underweight and obesity: insights from new global evidence.
    Lancet. 2024 Feb 29:S0140-6736(24)00051-5. doi: 10.1016/S0140-6736(24)00051.
    >> Share


  8. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.
    Lancet. 2024 Feb 29:S0140-6736(23)02750-2. doi: 10.1016/S0140-6736(23)02750.
    >> Share

  9. CAMPBELL P, Rutten FH, Lee MM, Hawkins NM, et al
    Heart failure with preserved ejection fraction: everything the clinician needs to know.
    Lancet. 2024 Feb 14:S0140-6736(23)02756-3. doi: 10.1016/S0140-6736(23)02756.
    >> Share

    January 2024
  10. THE LANCET
    Treating obesity and diabetes: drugs alone are not enough.
    Lancet. 2024;403:1.
    >> Share

    December 2023
  11. DANIELS JP
    Colombia introduces junk food tax.
    Lancet. 2023;402:2062.
    >> Share

    November 2023
  12. ZOU M, Northstone K, Leary S
    Causal effects of later-eating rhythm on adiposity in children through the comparison of two cohorts in the UK and China: a cross-cohort study.
    Lancet. 2023;402 Suppl 1:S99.
    >> Share

  13. ALRUBAIAN F, Mulla Z
    Governments policy measures to address obesity among adults: a scoping review of the global evidence.
    Lancet. 2023;402 Suppl 1:S20.
    >> Share

  14. CISNEROS AB, Headings R, Wells R, Reynolds C, et al
    Understanding the use of media analysis in public health research through food tax debates (HEALTHEI Project): a scoping review.
    Lancet. 2023;402 Suppl 1:S9.
    >> Share

  15. SPAVIN A, Moore A, Lunn J, Tucker F, et al
    Reflecting on parental insights into healthy lifestyles: a qualitative study.
    Lancet. 2023;402 Suppl 1:S85.
    >> Share

  16. CHEN S, Kuper H
    Tracing the temporal trends of modifiable risk factors in dementia: insights from the English Longitudinal Study of Ageing (2004-2019).
    Lancet. 2023;402 Suppl 1:S34.
    >> Share

  17. WALSH S, Wallace L, Kuhn I, Mytton O, et al
    Population-level interventions for the primary prevention of dementia: a complex evidence review.
    Lancet. 2023;402 Suppl 1:S13.
    >> Share

    October 2023
  18. KOTANI T, Tano S
    Long-term effects of gestational weight gain on mortality.
    Lancet. 2023 Oct 19:S0140-6736(23)01837-8. doi: 10.1016/S0140-6736(23)01837.
    >> Share

  19. HINKLE SN, Mumford SL, Grantz KL, Mendola P, et al
    Gestational weight change in a diverse pregnancy cohort and mortality over 50 years: a prospective observational cohort study.
    Lancet. 2023 Oct 19:S0140-6736(23)01517-9. doi: 10.1016/S0140-6736(23)01517.
    >> Share

    September 2023
  20. SUMITHRAN P, Finucane FM, Cohen RV
    Obesity drug shortages are symptomatic of wider malaise.
    Lancet. 2023 Sep 29:S0140-6736(23)01963-3. doi: 10.1016/S0140-6736(23)01963.
    >> Share

    June 2023
  21. GARVEY WT, Frias JP, Jastreboff AM, le Roux CW, et al
    Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
    Lancet. 2023 Jun 26:S0140-6736(23)01200-X. doi: 10.1016/S0140-6736(23)01200.
    >> Share

  22. APOVIAN CM, McDonnell ME
    CagriSema and the link between obesity and type 2 diabetes.
    Lancet. 2023 Jun 23:S0140-6736(23)01291-6. doi: 10.1016/S0140-6736(23)01291.
    >> Share

  23. KNOP FK, Aroda VR, do Vale RD, Holst-Hansen T, et al
    Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2023 Jun 23:S0140-6736(23)01185-6. doi: 10.1016/S0140-6736(23)01185.
    >> Share

  24. FALLOWS E, Ells L, Anand V
    Semaglutide and the future of obesity care in the UK.
    Lancet. 2023 Jun 5:S0140-6736(23)01083-8. doi: 10.1016/S0140-6736(23)01083.
    >> Share

    May 2023
  25. SKYLE D
    Fatima Cody Stanford: changing the narrative on obesity.
    Lancet. 2023;401:1644.
    >> Share

    April 2023
  26. MAHGOUB S, Newsome PN
    Bariatric-metabolic surgery versus lifestyle intervention in non-alcoholic steatohepatitis.
    Lancet. 2023 Apr 20:S0140-6736(23)00773-0. doi: 10.1016/S0140-6736(23)00773.
    >> Share

  27. VERRASTRO O, Panunzi S, Castagneto-Gissey L, De Gaetano A, et al
    Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00634-7. doi: 10.1016/S0140-6736(23)00634.
    >> Share

    February 2023
  28. PERDOMO CM, Cohen RV, Sumithran P, Clement K, et al
    Contemporary medical, device, and surgical therapies for obesity in adults.
    Lancet. 2023 Feb 9:S0140-6736(22)02403-5. doi: 10.1016/S0140-6736(22)02403.
    >> Share

    December 2022
  29. KRAMER CK, Leitao CB, Viana LV
    The impact of urbanisation on the cardiometabolic health of Indigenous Brazilian peoples: a systematic review and meta-analysis, and data from the Brazilian Health registry.
    Lancet. 2022;400:2074-2083.
    >> Share

    November 2022
  30. KRENZ K, McEachan R, Subiza-Perez M, Watmuff A, et al
    Exploring relationships between exposure to fast food outlets and childhood obesity at differing spatial resolutions: results from the Born in Bradford cohort study.
    Lancet. 2022;400 Suppl 1:S55.
    >> Share

  31. HESLEHURST N, Evans EH, Rodriguez ACI, Nagpal TS, et al
    Newspaper media framing of maternal obesity in the UK: a review and framework synthesis.
    Lancet. 2022;400 Suppl 1:S48.
    >> Share

  32. BIJLANI C, Vrinten C, Chang K, Hrobonova E, et al
    Changes in diet and physical activity after a pilot intervention to tackle childhood obesity in a deprived inner-London community: an observational cohort study.
    Lancet. 2022;400 Suppl 1:S22.
    >> Share

  33. BEYNON C
    Exploring the association between obesity and problems with peer relationships in children: a nationally representative cross-sectional study.
    Lancet. 2022;400 Suppl 1:S21.
    >> Share

    October 2022
  34. URVA S, Coskun T, Loh MT, Du Y, et al
    LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial.
    Lancet. 2022 Oct 27. pii: S0140-6736(22)02033.
    >> Share

    July 2022
  35. ABU DAYYEH BK, Bazerbachi F, Vargas EJ, Sharaiha RZ, et al
    Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial.
    Lancet. 2022 Jul 28. pii: S0140-6736(22)01280.
    >> Share

    June 2022
  36. GOLUBIC R, Barber TM, Caleyachetty R
    Obesity definition for personalised treatment of type 2 diabetes.
    Lancet. 2022;399:2189.
    >> Share

  37. LINGVAY I, Sumithran P, Cohen RV, Roux CWL, et al
    Obesity definition for personalised treatment of type 2 diabetes Authors' reply.
    Lancet. 2022;399:2189-2190.
    >> Share

  38. SHI Q, Wang Y, Li S
    Pharmacotherapy for adults with overweight and obesity - Authors' reply.
    Lancet. 2022;399:2101.
    >> Share

  39. DAYYEH BKA
    Adjustable intragastric balloon for obesity - Author's reply.
    Lancet. 2022;399:2100.
    >> Share

  40. STURGISS E, Ball L, Blane D, Hennessy M, et al
    Pharmacotherapy for adults with overweight and obesity.
    Lancet. 2022;399:2100-2101.
    >> Share

  41. CHARALAMPAKIS V, Rajeev Y, Singhal R
    Adjustable intragastric balloon for obesity.
    Lancet. 2022;399:2099.
    >> Share

  42. BRUNALDI VO, Neto MG
    Adjustable intragastric balloon for obesity.
    Lancet. 2022;399:2099.
    >> Share

    April 2022
  43. CROSBIE EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, et al
    Endometrial cancer.
    Lancet. 2022;399:1412-1428.
    >> Share

    February 2022
  44. TATUM M
    China's population peak.
    Lancet. 2022;399:509.
    >> Share

    December 2021
  45. SHI Q, Wang Y, Hao Q, Vandvik PO, et al
    Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)01640.
    >> Share

    November 2021
  46. LAU DCW, Erichsen L, Francisco AM, Satylganova A, et al
    Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial.
    Lancet. 2021 Nov 16. pii: S0140-6736(21)01751.
    >> Share

  47. ABU DAYYEH BK, Maselli DB, Rapaka B, Lavin T, et al
    Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial.
    Lancet. 2021 Nov 15. pii: S0140-6736(21)02394.
    >> Share

  48. SUDLOW A, le Roux CW
    Improving gastric balloons to treat obesity.
    Lancet. 2021 Nov 15. pii: S0140-6736(21)02505.
    >> Share

    September 2021
  49. LINGVAY I, Sumithran P, Cohen RV, le Roux CW, et al
    Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation.
    Lancet. 2021 Sep 30. pii: S0140-6736(21)01919.
    >> Share

    August 2021
  50. MEGHJI J, Mortimer K, Jayasooriya S, Marks GB, et al
    Lung health in LMICs: tackling challenges ahead - Authors' reply.
    Lancet. 2021;398:490.
    >> Share

  51. NEMERY B, Katoto PDMC, Develtere P
    Lung health in LMICs: tackling challenges ahead.
    Lancet. 2021;398:489-490.
    >> Share

  52. KHOO EM, Li D, Ungan M, Jordan R, et al
    Lung health in LMICs: tackling challenges ahead.
    Lancet. 2021;398:488-489.
    >> Share

    July 2021
  53. TEUFEL F, Seiglie JA, Geldsetzer P, Theilmann M, et al
    Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults.
    Lancet. 2021;398:238-248.
    >> Share

  54. WANG L, Zhou B, Zhao Z, Yang L, et al
    Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004-18.
    Lancet. 2021;398:53-63.
    >> Share

  55. FLEGAL KM
    BMI and obesity trends in Chinese national survey data.
    Lancet. 2021;398:5-7.
    >> Share

  56. SALAH RO, Ghandour R, Husseini A
    Prevalence of overweight, obesity, and associated factors among adolescents in the occupied Palestinian territory: a cross-sectional study.
    Lancet. 2021;398 Suppl 1:S46.
    >> Share

    June 2021
  57. TREASURE J, Ambwani S
    Addressing weight stigma and anti-obesity rhetoric in policy changes to prevent eating disorders.
    Lancet. 2021 Jun 3. pii: S0140-6736(21)01109.
    >> Share

    May 2021
  58. MINGRONE G, Bornstein SR
    Gain in survival after metabolic-bariatric surgery.
    Lancet. 2021;397:1785-1787.
    >> Share

  59. ENEBO LB, Berthelsen KK, Kankam M, Lund MT, et al
    Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial.
    Lancet. 2021;397:1736-1748.
    >> Share

  60. SYN NL, Cummings DE, Wang LZ, Lin DJ, et al
    Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.
    Lancet. 2021 May 6. pii: S0140-6736(21)00591.
    >> Share

    April 2021
  61. BECERRIL S, Fruhbeck G
    Cagrilintide plus semaglutide for obesity management.
    Lancet. 2021 Apr 22. pii: S0140-6736(21)00944.
    >> Share

    March 2021
  62. LATINI R, Staszewsky L
    Semaglutide and effective weight control.
    Lancet. 2021;397:942-943.
    >> Share

  63. DAVIES M, Faerch L, Jeppesen OK, Pakseresht A, et al
    Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.
    Lancet. 2021 Mar 2. pii: S0140-6736(21)00213.
    >> Share

    November 2020
  64. CHAN JCN, Lim LL, Wareham NJ, Shaw JE, et al
    The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32374.
    >> Share

    September 2020
  65. HAWKES C, Ruel M, Wells JC, Popkin BM, et al
    The double burden of malnutrition-further perspective - Authors' reply.
    Lancet. 2020;396:815-816.
    >> Share

  66. STEWART CP, de Pee S, Maleta K, Michaelsen KF, et al
    The double burden of malnutrition-further perspective.
    Lancet. 2020;396:814-815.
    >> Share

  67. OSENDARP SJM, Brown KH, Neufeld LM, Udomkesmalee E, et al
    The double burden of malnutrition-further perspective.
    Lancet. 2020;396:813.
    >> Share

  68. HOSSAIN MS, Ferdous S, Raheem E, Siddiqee MH, et al
    The double burden of malnutrition-further perspective.
    Lancet. 2020;396:813-814.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016